The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL?  Emmet E. McGrath, MB, PhD  Journal of Thoracic.

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
Neoplastic Fever Caused by Lung Cancer
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Antibody Independent Microfluidic Cell Capture of Circulating Tumor Cells for the Diagnosis of Cancer  Eric Lim, MB, ChB, MD, MSc, FRCS, Andee Tay, BSc,
SC17.02 Lung Cancer in China: Challenges and Perspectives
ALK FISH and IHC: You Cannot Have One without the Other
Cell signaling and cancer
Making Sense of HDAC2 Mutations in Colon Cancer
OPG/RANKL/RANK Pathway as a Therapeutic Target in Cancer
NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
Hedgehog Signaling Pathway and Lung Cancer
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer  Daniel Morgensztern, MD, Saiama.
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Frank Detterbeck, MD  Journal of Thoracic Oncology 
The Thymus and the Immune System: Layered Levels of Control
Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP 
Vascular Endothelial Growth Factor (VEGF) Pathway
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis
Tamas F. Molnar, Cengiz Gebitekin, Akif Turna 
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non–Small Cell Lung Cancer Patient  Jordi Remon, MD, Anas Gazzah, MD, Benjamin Besse,
Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
Strategies to Improve Outcomes of Patients with EGFR-Mutant Non–Small Cell Lung Cancer: Review of the Literature  Caicun Zhou, MD, PhD, Luan Di Yao, MD 
A Different Method in Diagnosis of Multiple Primary Lung Cancer
Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response 
Chemokines in the Biology of Lung Cancer
Vamsidhar Velcheti, MD  Journal of Thoracic Oncology 
Mitotic Inhibitors Journal of Thoracic Oncology
A Translational View of the Molecular Pathogenesis of Lung Cancer
Mirror Mirror on the Wall, Who Is the Fairest of Them All
The Number of Pulmonary Metastases: Influence on Practice and Outcome
MTP13-01: Indications and limitations of bronchoscopy
Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey  Daniel Morgensztern, MD, Shean Huey Ng,
Jennifer S. Temel, MD, William F. Pirl, MD, Christopher J
Pulmonary Metastasectomy in Breast Cancer
Phase I Study of Lenalidomide in Solid Tumors
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Silvia Bielsa, MD, José Martín-Juan, MD, José M
Antiangiogenesis Induced Tumor Cavitation in Lung Cancer
Recursive Partitioning Analysis Groups II–III Brain Metastases of Non-small Cell Lung Cancer: A Phase II Randomized Study Comparing Two Concurrent Chemoradiotherapy.
Genetic Changes in Squamous Cell Lung Cancer: A Review
Ethnic Differences in the Management of Lung Cancer in New Zealand
International Thymic Malignancies Interest Group: A Way Forward
European Lung Cancer Conference (ELCC) 2016 Organisation
Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer  Judith Elizabeth Carser, MB, BCh, MRCR, Yvonne Jane Summers,
S-1 Treatment for Chemorefractory Thymic Carcinoma
Intrathoracic Desmoid Tumor: Brief Report and Review of Literature
Pleural Metastases of Malignant Melanoma
IASLC 6th Latin American Conference on Lung Cancer
Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer
Epidemiology of Thymoma and Associated Malignancies
Who should decide margin length in pulmonary excision of lung cancer?
A B3 Type-Thymoma in a 7-Year-Old Child with Myasthenia Gravis
Rogerio C. Lilenbaum, MD, John Cashy, PhD, Thomas A
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
A Review of First-Line Treatment for Small-cell Lung Cancer
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Role of the Wnt Signaling Pathway and Lung Cancer
Robert Comis, MD, The Passing of a “Lung Man”
Presentation transcript:

The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL?  Emmet E. McGrath, MB, PhD  Journal of Thoracic Oncology  Volume 6, Issue 6, Pages 983-987 (June 2011) DOI: 10.1097/JTO.0b013e318217b6c8 Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 TRAIL induces apoptosis of transformed or malignant cells through both the intrinsic (mitochondrial) and extrinsic (death receptor/caspase) pathway. TRAIL, tumor necrosis factor-related apoptosis-inducing ligand. Journal of Thoracic Oncology 2011 6, 983-987DOI: (10.1097/JTO.0b013e318217b6c8) Copyright © 2011 International Association for the Study of Lung Cancer Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.